Comparative perilymph permeability of cephalosporins and its significance in the treatment and prevention of suppurative labyrinthitis

Annals of Otology, Rhinology and Laryngology

Volumn 105, Issue 1, 1996, Pages 54-57

  Sun, Ai Hua ^a,b,d   Parnes, Lorne S ^a,b,e   Freeman, David J ^a,c  

^a University of Western Ontario ^*

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

cephalosporins; labyrinthitis; meningitis

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEFUROXIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LABYRINTHITIS; MALE; NONHUMAN; PERILYMPH; PRIORITY JOURNAL;

EID: 0030038869     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949610500109     Document Type: Article

References (19)

1. Ballenger JJ, ed. Diseases of the nose, throat, ear, head and neck. 14th ed. Philadelphia, Pa: Lea & Febiger, 1991.
2. Prado S, Paparella MM. Sensorineural hearing loss secondary to bacterial infection. Otolaryngol Clin North Am 1978; 11:35-41.
3. Liebman EP, Ronis ML, Lovrinic JH, Katinsky SE. Hearing improvement following meningitis deafness. Arch Otolaryngol 1969;90:92-5.
4. Juhn SK, Rybak LP, Prado S. Nature of blood-labyrinth barrier in experimental conditions. Ann Otol Rhinol Laryngol 1981;90:135-41.
5. Sun AH, Parnes LS, Freeman DJ. Pharmacokinetic profiles of ceftazidime in cochlear perilymph, cerebrospinal fluid and plasma: a high-performance liquid chromatographic study. ORL J Otorhinolaryngol Relat Spec (in press).
6. Sun AH, Parnes LS, Freeman DJ. Cefuroxime: pharmacokinetics in cochlear perilymph, cerebrospinal fluid and plasma. J Otolaryngol 1995;24:134-7.
7. Ryan DM, Hodges B, Spencer GR, Harding SM. Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid. Antimicrob Agents Chemother 1982;22:995-8.
8. Connors JE, Dipiro JT, Hayter RG, Hooker KD, Stanfield JA, Young TR. Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion. Antimicrob Agents Chemother 1990;34:1128-31.
9. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clinical Pharmacokinet 1986;11:470-82.
10. Pfenninger J, Schaad UB, Lütschg J, Nussbaumer A, Zellweger U. Cefuroxime in bacterial meningitis. Arch Dis Child 1982;57:539-43.
11. Trallero EP, Arenzana JG, Ayestaran I, Baroja IM. Comparative activity in vitro of 16 antimicrobial agents against penicillin-susceptible meningococci and meningococci with diminished susceptibility to penicillin. Antimicrob Agents Chemother 1989;33:1622-3.
12. Clarke AM, Zemcov SJV. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics. J Antimicrob Chemother 1981;8(suppl B):57-62.
13. Bergogne-Berezin E, Morel C, Pierre J, Monrocq N, Dournovo P, Benard Y. Penetration of cefotaxime into bronchial secretions. Rev Infect Dis 1982;4(suppl):S392-S395.
14. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992;11: 662-6.
15. O'Callaghan CH, Acred P, Harper PB, Ryan DM, Kirby SM, Harding SM. GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother 1980;17:876-83.
16. Humbert G, Leroy A, Nair SR, Cherubin CE. Concentration of cefotaxime and desacetyl metabolite in serum and CSF of patients with meningitis. J Antimicrob Chemother 1984;13:487-94.
17. Novick WJ. Levels of cefotaxime in body fluids and tissues: a review. Rev Infect Dis 1982;4(suppl):S346-S353.
18. Fong IW, Tomking KB. Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation. Antimicrob Agents Chemother 1984; 26:115-6.
19. Bhatt S, Halpin C, Hsu W, et al. Hearing loss and pneumococcal meningitis: an animal model. Laryngoscope 1991;101: 1285-92.